Armistice Capital, LLC Cytokinetics Inc Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 1,023,390 shares of CYTK stock, worth $38.6 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
1,023,390
Previous 1,312,000
22.0%
Holding current value
$38.6 Million
Previous $61.7 Million
33.36%
% of portfolio
0.63%
Previous 0.87%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$553 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$447 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$375 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$301 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$229 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.55B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...